NFE2L2 and Alzheimer disease: However, activation of NRF2 transcription by the cruciferous-derived drug sulforaphane was able to reduce amyloid secretion, normalize cytokine release, and increase GSH secretion in AD astrocytes, suggesting a possible therapeutic strategy for AD [37].